---
title: Industry Updates, Webinars & More in October's Monthly Beat
---

Drug-Induced Arrhythmias: A Scientific Statement from the American Heart Association...

| View in browser OCTOBER   Drug-Induced Arrhythmias: A Scientific Statement from the American Heart Association Circulation   The AHA recently released a scientific statement surrounding the management of drug-induced arrhythmias including discontinuation of the offending medication and following treatment guidelines for the specific arrhythmia.       Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association Circulation   On Monday, the AHA released a scientific statement summarizing the current literature on the cardiorenal protective effects with SGLT2 inhibitors and GLP-1 receptor agonists in patients with CKD and T2D and provided practical guidance on a proposed collaborative care model.       Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure New England Journal of Medicine   In a recently released, double-blind trial of 3,730 patients those receiving empagliflozin had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes.        Dapagliflozin in Patients with Chronic Kidney Disease New England Journal of Medicine   A recently published study found that among patients with chronic kidney disease, the risk of a composite of a sustained decline in the estimated GFR of at least 50%, end-stage kidney disease, or death from renal or cardiovascular causes was significantly lower with dapagliflozin than with placebo.         READ BLOG   CMHC Chair, George L. Bakris, MD and Senior Planning Committee member Clyde W. Yancy, MD, MSc, MACP discuss gender equality and race issues in the treatment of heart failure. WATCH NOW     Lemon zest ties all the flavors together in this light and creamy pasta!   New CMHC Live Online Specialty Series       Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700 Unsubscribe Manage preferences |
| --- |